TBPH Operating Expenses
Theravance Biopharma Inc · Operating Expenses
TBPH Operating Expenses
Latest reported$19.89Mperiod ending
TBPH Quarterly Operating Expenses ($32.60M → $19.89M)
Quarterly operating expenses
High-resolution chart · PNG
TBPH operating expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 19,892,000 | |
| 23,549,000 | |
| 26,820,000 | |
| 18,333,000 | |
| 18,430,000 | |
| 18,370,000 | |
| 18,501,000 | |
| 18,437,000 | |
| 20,007,000 | |
| 16,742,000 | |
| 15,492,000 | |
| 23,114,000 | |
| 20,447,000 | |
| 20,757,000 | |
| 16,732,000 | |
| 16,786,000 | |
| 19,227,000 | |
| 27,166,000 | |
| 39,887,000 | |
| 23,070,000 | |
| 25,931,000 | |
| 30,550,000 | |
| 30,055,000 | |
| 94,872,000 | |
| 87,184,000 | |
| 92,338,000 | |
| 100,071,000 | |
| 77,628,000 | |
| 68,626,000 | |
| 79,004,000 | |
| 77,726,000 | |
| 74,583,000 | |
| 73,628,000 | |
| 72,469,000 | |
| 80,575,000 | |
| 60,287,000 | |
| 67,266,000 | |
| 61,351,000 | |
| 62,379,000 | |
| 52,237,000 | |
| 52,330,000 | |
| 59,274,000 | |
| 56,466,000 | |
| 53,212,000 | |
| 51,922,000 | |
| 57,767,000 | |
| 63,964,000 | |
| 56,029,000 | |
| 59,401,000 | |
| 60,775,000 | |
| 44,255,000 | |
| 41,102,000 | |
| 38,957,000 | |
| 32,196,000 | |
| 67,145,000 | |
| 32,595,000 |